Cargando…
Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition
As populations age, prevalence of Alzheimer's disease (AD) is rising. Over 100 years of research has provided valuable insights into the pathophysiology of the disease, for which age is the principal risk factor. However, in recent years, a multitude of clinical trial failures has led to pharma...
Autores principales: | Denver, Paul, McClean, Paula L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128051/ https://www.ncbi.nlm.nih.gov/pubmed/30136683 http://dx.doi.org/10.4103/1673-5374.238608 |
Ejemplares similares
-
Alzheimer’s disease, mild cognitive impairment, and normal aging distinguished by multi-modal parcellation and machine learning
por: Sheng, Jinhua, et al.
Publicado: (2020) -
Effectiveness of regional DTI measures in distinguishing Alzheimer's
disease, MCI, and normal aging()
por: Nir, Talia M., et al.
Publicado: (2013) -
Early Stage Glycosylation Biomarkers in Alzheimer’s Disease
por: Regan, Patricia, et al.
Publicado: (2019) -
Dysregulation of antimicrobial peptide expression distinguishes Alzheimer’s disease from normal aging
por: Wang, Min, et al.
Publicado: (2020) -
On the Need to Distinguish between Insulin-Normal and Insulin-Resistant Patients in Testosterone Therapy
por: Zolla, Lello
Publicado: (2022)